Navigation Links
Sensus Healthcare and Texas Dermatology Associates at Baylor University Medical Center Announce the Formation of the SRT University™ Comprehensive Education Series for Practitioners, Healthcare Professionals, and Patients
Date:5/18/2012

BOCA RATON, Fla., May 18, 2012 /PRNewswire/ -- Sensus Healthcare and Texas Dermatology Associates at Baylor University Medical Center of Dallas, TX are proud to announce the establishment of the SRT University™ Comprehensive Education Series for practitioners, healthcare professionals, and patients. SRT University™ will offer multi-tiered education and training curriculums for the provider and patient populations.  The objectives are to increase the awareness and proficiency in utilizing superficial radiotherapy and its many benefits to treat non-melanoma skin cancers.

(Logo: http://photos.prnewswire.com/prnh/20110124/FL34943LOGO )

SRT University™ will provide physicians and healthcare professionals academic-grade expert training on the science, physics, practice workflow, and patient management pertaining to superficial radiotherapy in treating non-melanoma skin cancers.  Training will be delivered via online, live and on-demand broadcasts, and hands-on modules.

Dr. Dan McCoy, who will lead the clinician content development team, said, "We are extremely excited to be involved in this project with Sensus Healthcare to bring this treatment modality back to the forefront of skin cancer therapy in dermatology and to train practitioners and healthcare professionals to use this technology for optimal outcomes for our patients."

Joe Sardano, President and CEO of Sensus Healthcare, said, "We are honored and excited to partner with Dr. McCoy and his team in establishing a world-class expert education program that will benefit the patients, optimize clinical outcomes, and help the physicians and healthcare professionals to constantly hone their skills and essentially create an idea-sharing and knowledge proliferation professional community, while increasing patient awareness of superficial radiotherapy as a viable treatment option for their non-melanoma skin cancer."

About Sensus Healthcare:
Sensus Healthcare specializes in making proven non-melanoma skin cancer solutions more accessible to patients. Our dedicated superficial radiation therapy (SRT) systems are designed specifically to provide an alternative to surgical procedures for basal cell and squamous cell carcinomas. Our mobile, compact SRT-100™ systems are used widely by oncologists and dermatologists to bring non-melanoma skin cancer treatment to more patients in more settings. We also offer a professional skin care line, Sensus Skin Solutions™, through our physician SRT-100™ users for their patients.

About Texas Dermatology Associates at Baylor Medical Center:
Texas Dermatology Associates at Baylor Medical Center is a comprehensive clinic specializing in the treatment of a wide variety of skin diseases since 1974.  Dr. Alan Menter, Senior Partner, is internationally known for his work in the treatment of psoriasis, and Dr. Dan McCoy, Managing Partner, is Medical Director for the Baylor Sammons Cancer Center Skin Tumor and Melanoma Clinic.  Texas Dermatology is the primary clinical site for the Baylor University Medical Center Dermatology Residency Program.  The providers and staff at Texas Dermatology have contributed over 300 articles in prestigious medical journals, nationally and internationally, as well as lecturing extensively. The Menter Dermatology Research Institute is a leading innovator in dermatology research.

Contact:

Michelle Verina
Public Relations
561-922-5808 Ext 108
michelle@sensushealthcare.com


'/>"/>
SOURCE Sensus Healthcare
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use
2. Agendias Breast Cancer Recurrence Test MammaPrint Included in International St. Gallen Expert Consensus Recommendations
3. Ipsogen Reports Incorporation of the Genomic Grade in the 2009 St. Gallen International Consensus Meeting on the Primary Treatment of Early Breast Cancer
4. TOPEX Sells Skin Cancer Business Operations to SENSUS Healthcare
5. Sensus Healthcare Awarded Sole Contract for Superficial Radiotherapy
6. Boston Scientific Second Quarter Results Exceed Consensus Sales and EPS; Full-Year Guidance Raised
7. 2011 Consensus Panel Issues New Guidelines for Intrathecal Pain Management
8. International Panel of Leading Bariatric Surgeons Reaches Consensus on Optimal Techniques for Laparoscopic Sleeve Gastrectomy
9. Ameritox Supports New Expert Consensus Recommendations For Patients on Long-Term Opioid Therapy
10. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
11. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
(Date:6/23/2016)... and INDIANAPOLIS , June ... receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship is any ... scholarship winners, announced today online at www.diabetesscholars.org ... type 1 diabetes stand in the way of academic ... supported the Foundation,s scholarship program since 2012, and continues ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
(Date:6/26/2016)... ... , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... a whole new perspective by using the title layers in ProSlice Levels to ... ProSlice Levels contains over 30 Different presets to choose from. FCPX users ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
Breaking Medicine News(10 mins):